Toubeau G, Nonclercq D, Zanen J, Lambricht P, Tulkens P M, Heuson-Stiennon J A, Laurent G
Service d'Histologie et de Cytologie Expérimentale, Faculté de Médecine, Université de Mons-Hainaut, Belgium.
Kidney Int. 1991 Oct;40(4):691-9. doi: 10.1038/ki.1991.262.
The distribution of epidermal growth factor (EGF) was examined by immunocytochemistry in the kidneys of rats exposed to amikacin, an aminoglycoside antibiotic causing tubular necrosis at high dose. Five-animal groups were treated for 4 or 10 days with amikacin at daily doses of 15, 40, 80 or 200 mg/kg. The drug was delivered i.p. twice a day. One hour before termination, each rat received an i.p. injection of [3H] thymidine to evaluate DNA synthesis in renal tissue. After sacrifice, the kidneys were processed for morphological (semithin and paraffin sections) and biochemical analysis (measurement of DNA synthesis by [3H] thymidine incorporation in vivo). Amikacin induced in proximal tubules a dose-related lysosomal phospholipidosis, which was assessed by the morphometric evaluation of altered lysosomes ("myeloid bodies") on semithin section. However, frank evidence of acute tubular necrosis was only observed in rats receiving amikacin at a daily dose of 200 mg/kg. Concomitantly with the development of tubular necrosis, there was a rise in the rate of cell turnover, reflected by an increase of DNA synthesis in renal tissue. This sign of tubular regeneration was accompanied by a redistribution of EGF immunoreactivity, as revealed by immunocytochemical staining. Within renal cortex of control rats, EGF immunoreactivity predominantly appeared in distal tubules and collecting ducts (97% of examined tubular sections). In contrast, in treated animals where the renal cortex displayed evidence of tubular necrosis/regeneration, EGF immunoreactivity was frequently associated with proximal tubules (more than 30% of examined tubular sections, as compared to 3% in controls).(ABSTRACT TRUNCATED AT 250 WORDS)
采用免疫细胞化学方法检测了暴露于阿米卡星(一种高剂量时可导致肾小管坏死的氨基糖苷类抗生素)的大鼠肾脏中表皮生长因子(EGF)的分布情况。将五组动物分别以每日15、40、80或200mg/kg的剂量腹腔注射阿米卡星,持续4天或10天。药物每天腹腔注射两次。在处死前1小时,每只大鼠腹腔注射[3H]胸腺嘧啶核苷,以评估肾组织中的DNA合成。处死后,对肾脏进行形态学(半薄切片和石蜡切片)和生化分析(通过体内[3H]胸腺嘧啶核苷掺入法测量DNA合成)。阿米卡星在近端小管中诱导出剂量相关的溶酶体磷脂沉积症,通过对半薄切片上改变的溶酶体(“髓样小体”)进行形态计量学评估来确定。然而,仅在接受每日200mg/kg阿米卡星的大鼠中观察到明显的急性肾小管坏死证据。伴随肾小管坏死的发展,细胞更新率升高,表现为肾组织中DNA合成增加。免疫细胞化学染色显示,这种肾小管再生的迹象伴随着EGF免疫反应性的重新分布。在对照大鼠的肾皮质中,EGF免疫反应性主要出现在远端小管和集合管中(97%的检查肾小管切片)。相比之下,在肾皮质显示出肾小管坏死/再生证据的处理动物中,EGF免疫反应性经常与近端小管相关(超过30%的检查肾小管切片,而对照组为3%)。(摘要截短于250字)